Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Children's Oncology Group
M.D. Anderson Cancer Center
University of Washington
Stanford University